Matches in SemOpenAlex for { <https://semopenalex.org/work/W2294720611> ?p ?o ?g. }
- W2294720611 endingPage "120" @default.
- W2294720611 startingPage "91" @default.
- W2294720611 abstract "The vast majority of morbidity and mortality in cystic fibrosis (CF) patients is due to lung disease caused by mutations in the gene encoding the CF transmembrane conductance regulator (CFTR). CFTR is a PKA-regulated anion channel localized in the apical membrane of bronchial epithelia where it controls salt and fluid regulation to facilitate bacteria clearance. There are over 1000 disease-causing mutations in the gene encoding CFTR and, depending on the type of mutation, the cell surface density and/or functional activity of CFTR in the apical membrane is reduced. A therapeutic strategy for the treatment of lung disease in CF patients is to use pharmacological agents that increase mutant CFTR-mediated anion secretion. High-throughput screening strategies have identified multiple chemotypes that increase mutant CFTR-mediated anion secretion. These chemotypes can be grouped into two classes based on their mode of action. The first class is known as CFTR correctors because they correct the processing and trafficking of CFTR to increases its cell surface density. The second class is known as CFTR potentiators as they potentiate the amount of anion secretion through CFTR at the cell surface. In vivo analysis of CFTR activity in CF patients indicates that it is correlated with the severity of lung disease and supports the hypothesis that CFTR modulators that restore mutant CFTR activity to >10% of wild-type-CFTR would improve lung function. The use of high-throughput screening and medicinal chemistry optimization to improve the efficacy, potency, and pharmaceutical properties of the multiple potentiator or corrector scaffolds identified to date offers a promising approach for the treatment of CF by directly targeting the root cause of the disease." @default.
- W2294720611 created "2016-06-24" @default.
- W2294720611 creator A5011486449 @default.
- W2294720611 creator A5027269456 @default.
- W2294720611 creator A5081109279 @default.
- W2294720611 date "2008-01-01" @default.
- W2294720611 modified "2023-09-26" @default.
- W2294720611 title "Pharmacological Rescue of Mutant CFTR Function for the Treatment of Cystic Fibrosis" @default.
- W2294720611 cites W1516558899 @default.
- W2294720611 cites W1547921699 @default.
- W2294720611 cites W1606812696 @default.
- W2294720611 cites W1677528798 @default.
- W2294720611 cites W1745204207 @default.
- W2294720611 cites W1963571125 @default.
- W2294720611 cites W1965444834 @default.
- W2294720611 cites W1967064450 @default.
- W2294720611 cites W1974227479 @default.
- W2294720611 cites W1975536724 @default.
- W2294720611 cites W1975971473 @default.
- W2294720611 cites W1976507289 @default.
- W2294720611 cites W1977911415 @default.
- W2294720611 cites W1982071077 @default.
- W2294720611 cites W1983020696 @default.
- W2294720611 cites W1983727167 @default.
- W2294720611 cites W1983746433 @default.
- W2294720611 cites W1990035962 @default.
- W2294720611 cites W1996779865 @default.
- W2294720611 cites W1998649792 @default.
- W2294720611 cites W1999816913 @default.
- W2294720611 cites W2004844038 @default.
- W2294720611 cites W2004991882 @default.
- W2294720611 cites W2005285859 @default.
- W2294720611 cites W2007415402 @default.
- W2294720611 cites W2007936771 @default.
- W2294720611 cites W2016532191 @default.
- W2294720611 cites W2016728833 @default.
- W2294720611 cites W2019697237 @default.
- W2294720611 cites W2030524479 @default.
- W2294720611 cites W2031025422 @default.
- W2294720611 cites W2032258216 @default.
- W2294720611 cites W2036774130 @default.
- W2294720611 cites W2037922224 @default.
- W2294720611 cites W2039599894 @default.
- W2294720611 cites W2046084748 @default.
- W2294720611 cites W2047198892 @default.
- W2294720611 cites W2048959140 @default.
- W2294720611 cites W2050573110 @default.
- W2294720611 cites W2051086778 @default.
- W2294720611 cites W2052588826 @default.
- W2294720611 cites W2054983059 @default.
- W2294720611 cites W2059699662 @default.
- W2294720611 cites W2063641892 @default.
- W2294720611 cites W2067367508 @default.
- W2294720611 cites W2068233575 @default.
- W2294720611 cites W2075257287 @default.
- W2294720611 cites W2079234445 @default.
- W2294720611 cites W2081809273 @default.
- W2294720611 cites W2082968284 @default.
- W2294720611 cites W2084345535 @default.
- W2294720611 cites W2084491822 @default.
- W2294720611 cites W2085633946 @default.
- W2294720611 cites W2094703380 @default.
- W2294720611 cites W2095028236 @default.
- W2294720611 cites W2096580943 @default.
- W2294720611 cites W2100662763 @default.
- W2294720611 cites W2103634965 @default.
- W2294720611 cites W2106537884 @default.
- W2294720611 cites W2110652155 @default.
- W2294720611 cites W2116698714 @default.
- W2294720611 cites W2116811505 @default.
- W2294720611 cites W2116885714 @default.
- W2294720611 cites W2117316776 @default.
- W2294720611 cites W2117669007 @default.
- W2294720611 cites W2122131707 @default.
- W2294720611 cites W2122415153 @default.
- W2294720611 cites W2125460059 @default.
- W2294720611 cites W2126609769 @default.
- W2294720611 cites W2128984788 @default.
- W2294720611 cites W2129257665 @default.
- W2294720611 cites W2130619361 @default.
- W2294720611 cites W2136025669 @default.
- W2294720611 cites W2138127281 @default.
- W2294720611 cites W2139398847 @default.
- W2294720611 cites W2146335990 @default.
- W2294720611 cites W2151502323 @default.
- W2294720611 cites W2153075441 @default.
- W2294720611 cites W2157182914 @default.
- W2294720611 cites W2159997339 @default.
- W2294720611 cites W2167724548 @default.
- W2294720611 cites W2170175853 @default.
- W2294720611 cites W2177357464 @default.
- W2294720611 cites W2184141508 @default.
- W2294720611 cites W2189357378 @default.
- W2294720611 cites W2269547969 @default.
- W2294720611 cites W2336764462 @default.
- W2294720611 cites W2410997911 @default.
- W2294720611 cites W2789633529 @default.
- W2294720611 cites W2992678825 @default.